Filing Details

Accession Number:
0001138723-11-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-04 21:18:08
Reporting Period:
2011-09-30
Filing Date:
2011-10-04
Accepted Time:
2011-10-04 21:18:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138723 Accuray Inc ARAY Surgical & Medical Instruments & Apparatus (3841) 770268932
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1464809 J. Darren Milliken 1310 Chesapeake Terrace
Sunnyvale CA 94089
Svp General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-30 6,750 $0.00 15,323 No 4 A Direct
Common Stock Disposition 2011-10-01 628 $3.55 14,695 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2011-09-30 26,000 $0.00 26,000 $4.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,000 2021-09-30 No 4 A Direct
Footnotes
  1. The restricted stock units (RSUs) are released as they vest. A total of 25% of the shares subject to this grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares vest and are released at a rate of 25% a year on each anniversiary of the vesting commencement date over the remaining three years.
  2. Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
  3. The shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 48-months, beginning on October 1, 2011.